Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693–733.

Article  CAS  PubMed  Google Scholar 

Maubach G, Schmädicke AC, Naumann M. NEMO links nuclear factor-kappaB to human diseases. Trends Mol Med. 2017;23:1138–55.

Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651.

Article  PubMed  PubMed Central  Google Scholar 

Orange JS, Levy O, Geha RS. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev. 2005;203:21–37.

Article  CAS  PubMed  Google Scholar 

Courtois G, Gilmore TD. Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene. 2006;25:6831–43.

Article  CAS  PubMed  Google Scholar 

Puel A, Picard C, Ku CL, Smahi A, Casanova JL. Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol. 2004;16:34–41.

Article  CAS  PubMed  Google Scholar 

Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ, et al. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122:1169–1177. e16.

Fusco F, Pescatore A, Conte MI, Mirabelli P, Paciolla M, Esposito E, et al. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-kappaB pathway can cause immunodeficiency and/or inflammation. Int Rev Immunol. 2015;34:445–59.

Cammarata-Scalisi F, Fusco F, Ursini MV. Incontinentia pigmenti. Actas Dermosifiliogr (Engl Ed). 2019;110:273–8.

Article  CAS  PubMed  Google Scholar 

Minić S, Trpinac D, Obradović M. Incontinentia pigmenti diagnostic criteria update. Clin Genet. 2014;85:536–42.

Martinez-Gayosso A, Garcia-Romero MT. Incontinentia pigmenti: multisistemic genodermatosis. Bol Med Hosp Infant Mex. 2020;77(3):112–8

Fusco F, Paciolla M, Conte MI, Pescatore A, Esposito E, Mirabelli P, et al. Incontinentia pigmenti: report on data from 2000 to 2013. Orphanet J Rare Dis. 2014;9:93.

Sharp A, Robinson D, Jacobs P. Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet. 2000;107:343–9.

Article  CAS  PubMed  Google Scholar 

Boisson B, Honda Y, Ajiro M, Bustamante J, Bendavid M, Gennery AR, et al. Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency. J Clin Invest. 2019;129(2):583–97.

Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000;405(6785):466–72.

Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000;67:1555–62.

Fusco F, Pescatore A, Bal E, Ghoul A, Paciolla M, Lioi MB, et al. Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations. Hum Mutat. 2008;29:595–604.

Dupuis-Girod S, Corradini N, Hadj-Rabia S, Fournet JC, Faivre L, Le Deist F, et al. Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics. 2002;109:e97.

Ohnishi H, Kishimoto Y, Taguchi T, Kawamoto N, Nakama M, Kawai T, et al. Immunodeficiency in two female patients with incontinentia pigmenti with heterozygous NEMO mutation diagnosed by LPS unresponsiveness. J Clin Immunol. 2017;37:529–38.

Kosaki K, Shimasaki N, Fukushima H, Hara M, Ogata T, Matsuo N. Female patient showing hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID). Am J Hum Genet. 2001;69:664–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez-Pomar N, Munoz-Saa I, Heine-Suner D, Martin A, Smahi A, Matamoros N. A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency. Hum Genet. 2005;118:458–65.

Article  PubMed  Google Scholar 

Mou W, Yang S, Guo R, Fu L, Zhang L, Guo W, et al. A novel homozygous TTC7A missense mutation results in familial multiple intestinal atresia and combined immunodeficiency. Front Immunol. 2021;12:759308.

Kremserova S, Nauseef WM. Isolation of human neutrophils from venous blood. Methods Mol Biol. 2020;2087:33–42.

Article  PubMed  Google Scholar 

Mou W, Gao L, He J, Yin J, Xu B, Gui J. Compound heterozygous DCLRE1C mutations lead to clinically typical severe combined immunodeficiency presenting with graft versus host disease. Immunogenetics. 2021;73:425–34.

Article  CAS  PubMed  Google Scholar 

Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992;51:1229–39.

CAS  PubMed  PubMed Central  Google Scholar 

Nenci A, Huth M, Funteh A, Schmidt-Supprian M, Bloch W, Metzger D, et al. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum Mol Genet. 2006;15:531–42.

Liao SL, Lai SH, Huang JL, Lee NC, Lee WI. Serial cytokine expressions in infants with incontinentia pigmenti. Immunobiology. 2013;218:772–9.

Article  CAS  PubMed  Google Scholar 

Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557–61.

Mitani Y, Wada T, Matsuda Y, Sakai S, Yachie A. XL-EDA-ID Presenting with congenital duodenal atresia and perforations. J Clin Immunol. 2018;38:733–5.

Article  PubMed  Google Scholar 

Márquez Balbás G, González-Enseñat MA, Vicente A, Creus-Vila L, Antón J, Umbert-Millet P. Incontinentia pigmenti and bipolar aphthosis: an unusual combination. ISRN Dermatol. 2011;2011:814186.

Cheng LE, Kanwar B, Tcheurekdjian H, Grenert JP, Muskat M, Heyman MB, et al. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin Immunol. 2009;132:124–31.

Parrish JE, Scheuerle AE, Lewis RA, Levy ML, Nelson DL. Selection against mutant alleles in blood leukocytes is a consistent feature in incontinentia pigmenti type 2. Hum Mol Genet. 1996;5:1777–83.

Article  CAS  PubMed  Google Scholar 

Conte MI, Pescatore A, Paciolla M, Esposito E, Miano MG, Lioi MB, et al. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease. Hum Mutat. 2014;35:165–77.

Fusco F, Bardaro T, Fimiani G, Mercadante V, Miano MG, Falco G, et al. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation. Hum Mol Genet. 2004;13:1763–73.

Mizukami T, Obara M, Nishikomori R, Kawai T, Tahara Y, Sameshima N, et al. Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J Clin Immunol. 2012;32(1):39–49.

Klemann C, Pannicke U, Morris-Rosendahl DJ, Vlantis K, Rizzi M, Uhlig H, et al. Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency. Clin Immunol. 2016;164:52–6.

Miot C, Imai K, Imai C, Mancini AJ, Kucuk ZY, Kawai T, et al. Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations. Blood. 2017;130(12):1456–67.